Infection of human enteroendocrine cells with Chlamydia trachomatis: A possible model for pathogenesis in irritable bowel syndrome

Neurogastroenterology and Motility

Volumn 23, Issue 10, 2011, Pages 928-934

  Dlugosz, A ^a   Zakikhany, K ^a   Muschiol, S ^b   Hultenby, K ^a   Lindberg, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chlamydia trachomatis; Chromogranin A; Enteroendocrine cells; Infection; Irritable bowel syndrome; Serotonin; Vesicular monoamine transporter

Indexed keywords

CHROMOGRANIN A; PENICILLIN G; SEROTONIN; VESICULAR MONOAMINE TRANSPORTER 1;

ARTICLE; BACTERIAL STRAIN; CELL SECRETION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CHLAMYDIASIS; COLON TUMOR; DOWN REGULATION; ENTEROENDOCRINE CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRITABLE COLON; JEJUNUM BIOPSY; PATHOGENESIS; PERSISTENT INFECTION; PRIORITY JOURNAL;

CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; ENTEROENDOCRINE CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HUMANS; IRRITABLE BOWEL SYNDROME; MICROSCOPY, ELECTRON, TRANSMISSION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84860410046     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2011.01765.x     Document Type: Article

References (26)

1. Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis 2009; 41: 844-9.
2. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003; 124: 1662-71.
3. Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol 2009; 15: 3591-6.
4. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997; 314: 779-82.
5. Dlugosz A, Tornblom H, Mohammadian G et al. Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome. BMC Gastroenterol 2010; 10: 19.
6. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000; 95: 2698-709.
7. Jakobsen AM, Andersson P, Saglik G et al. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours. J Pathol 2001; 195: 463-72.
8. Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clin Chim Acta 2009; 403: 47-55.
9. Modlin IM, Gustafsson BI, Moss SF, Pavel M, Tsolakis AV, Kidd M. Chromogranin A - biological function and clinical utility in neuro endocrine tumor disease. Ann Surg Oncol 2010; 17: 2427-43.
10. Day R, Gorr SU. Secretory granule biogenesis and chromogranin A: master gene, on/off switch or assembly factor? Trends Endocrinol Metab 2003; 14: 10-3.
11. Kim T, Tao-Cheng JH, Eiden LE, Loh YP. Chromogranin A, an 'on/off' switch controlling dense-core secretory granule biogenesis. Cell 2001; 106: 499-509.
12. Sciola V, Massironi S, Conte D et al. Plasma chromogranin a in patients with inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 867-71.
13. Sidhu R, McAlindon ME, Leeds JS, Skilling J, Sanders DS. The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome. J Gastrointestin Liver Dis 2009; 18: 23-6.
14. Beatty WL, Byrne GI, Morrison RP. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol 1994; 2: 94-8.
15. Mpiga P, Ravaoarinoro M. Chlamydia trachomatis persistence: an update. Microbiol Res 2006; 161: 9-19.
16. Boleti H, Benmerah A, Ojcius DM, Cerf-Bensussan N, Dautry-Varsat A. Chlamydia infection of epithelial cells expressing dynamin and Eps15 mutants: clathrin-independent entry into cells and dynamin-dependent productive growth. J Cell Sci 1999; 10: 1487-96.
17. Muschiol S, Bailey L, Gylfe A et al. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A 2006; 103: 14566-71.
18. Skilton RJ, Cutcliffen LT, Barlow D et al. Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle. PLoS ONE 2009; 4: e7723.
19. Cloez-Tayarani I, Changeux JP. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol 2007; 81: 599-606.
20. Khan WI, Ghia JE. Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol 2010; 161: 19-27.
21. Shooshtarizadeh P, Zhang D, Chich JF et al. The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity. Regul Pept 2010; 165: 102-10.
22. Kidd M, Gustafsson BI, Drozdov I, Modlin IM. IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil 2009; 21: 439-50.
23. Palazzo M, Balsari A, Rossini A et al. Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J Immunol 2007; 178: 4296-303.
24. Langhorst J, Junge A, Rueffer A et al. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol 2009; 104: 404-10.
25. Wimalasena K. Vesicular monoamine transporters: Structure-function, pharmacology, and medicinal chemistry. Med Res Rev 2011; 31:483-519.
26. Kim HS, Lim JH, Park H, Lee SI. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3years after acute Shigella infection - an observation in a small case control study. Yonsei Med J 2010; 51: 45-51.